Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan vs Atenolol in Marfan Syndrome
NCT00593710Phase 2Completed
- Sponsor
- University of British Columbia
- Start
- Jan 2008
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of losartan in Marfan syndrome (MFS) (2 arms), sponsored by University of British Columbia. Primary endpoint: Pulse Wave Velocity at 12 months. Started Jan 2008; status: completed.
02
Drugs
losartan
03
Conditions
Marfan syndrome (MFS)
Beyond the preview
Go deeper on NCT00593710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00593710.